Mycophenolate Mofetil Reduces Renal Injury in the Chronic Nitric Oxide Synthase Inhibition Model
- 1 January 2001
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 37 (1), 170-175
- https://doi.org/10.1161/01.hyp.37.1.170
Abstract
Abstract —We and others have recently shown that mycophenolate mofetil (MMF) reduces renal inflammation and glomerular and interstitial injury in the 5/6 renal ablation model. In the present study, we investigated whether MMF limits renal injury in a model of chronic nitric oxide (NO) inhibition associated with a high-salt diet and characterized by progressive systemic hypertension, albuminuria, glomerular sclerosis and ischemia, interstitial expansion, and progressive macrophage infiltration. Adult male Münich-Wistar rats were distributed among 3 groups: HS, rats receiving a high-salt diet (3.2% Na); HS+N, HS rats orally treated with the NO inhibitor N ω -nitro- l -arginine methyl ester (L-NAME), 25 mg · kg −1 · d −1 ; and HS+N+MMF, HS+N rats orally treated with MMF, 10 mg · kg −1 · d −1 . Renal hemodynamics were studied after 15 days of treatment; histological and immunohistochemical studies were conducted after 30 days of treatment. MMF treatment did not reverse the hemodynamic alterations characteristic of this model. Renal injury in the HS+N group was associated with macrophage and lymphocyte infiltration. Treatment with MMF reduced glomerular and interstitial injury and limited macrophage and lymphocyte infiltration. These results suggest that renal inflammation is a strong independent factor in the pathogenesis of the nephropathy associated with the HS+N model.Keywords
This publication has 20 references indexed in Scilit:
- Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathwayJCI Insight, 1999
- Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in ratsKidney International, 1999
- Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.JCI Insight, 1998
- Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized ratsKidney International, 1996
- Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.JCI Insight, 1995
- EFFECTS OF RS61443 ON FUNCTIONAL AND MORPHOLOGICAL CHANGES IN CHRONICALLY REJECTING RAT KIDNEY ALLOGRAFTS1,2Transplantation, 1995
- IN SITU EXPRESSION OF TUMOR NECROSIS FACTOR-ALPHA, INTERFERON-GAMMA, AND INTERLEUKIN-2 RECEPTORS IN RENAL ALLOGRAFT BIOPSIESTransplantation, 1992
- Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.Hypertension, 1992
- Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage.JCI Insight, 1992
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMThe Lancet, 1987